Keefe Bruyette analyst David Konrad raised the firm's price target on Chemung Financial to $72 from $64 and keeps a Market Perform rating on the shares. The firm views the company's Q1 report as "impressive." Chemung's outlook is "stable" with "strong growth and some normalization in fees/expenses," the analyst tells investors in a research note.
